It is interesting to note that mutations in PNPLA3, MBOAT7, and TM6SF2 are associated with fatty liver disease; however, TM6SF2 has a contrasting effect on CKD compared to mutations in PNPLA3 and MBOAT7. This evidence concerns the gene PNPLA3 and fatty liver disease.